179 related articles for article (PubMed ID: 31396219)
1. Tissue Cytokine IL-33 Modulates the Cytotoxic CD8 T Lymphocyte Activity During Nutrient Deprivation by Regulation of Lineage-Specific Differentiation Programs.
Dreis C; Ottenlinger FM; Putyrski M; Ernst A; Huhn M; Schmidt KG; Pfeilschifter JM; Radeke HH
Front Immunol; 2019; 10():1698. PubMed ID: 31396219
[TBL] [Abstract][Full Text] [Related]
2. Enhanced CXCR4 Expression of Human CD8
Burkard T; Dreis C; Herrero San Juan M; Huhn M; Weigert A; Pfeilschifter JM; Radeke HH
Front Immunol; 2021; 12():668884. PubMed ID: 34504486
[TBL] [Abstract][Full Text] [Related]
3. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
4. B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD8+ cytotoxic T lymphocyte precursors.
Hiraoka S; Takeuchi N; Bian Y; Nakahara H; Kogo M; Dunussi-Joannopoulos K; Wolf S; Ono S; Fujiwara H
Int Immunol; 2005 Aug; 17(8):1071-9. PubMed ID: 16027141
[TBL] [Abstract][Full Text] [Related]
5. IL-12 and IL-4 activate a CD39-dependent intrinsic peripheral tolerance mechanism in CD8(+) T cells.
Noble A; Mehta H; Lovell A; Papaioannou E; Fairbanks L
Eur J Immunol; 2016 Jun; 46(6):1438-48. PubMed ID: 26990545
[TBL] [Abstract][Full Text] [Related]
6. Role of IL-2, IL-4 and IL-6 in the growth and differentiation of tumor-specific CD4+ T helper and CD8+ T cytotoxic cells.
Selvan RS; Nagarkatti PS; Nagarkatti M
Int J Cancer; 1990 Jun; 45(6):1096-104. PubMed ID: 1972141
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous mechanisms of human cytotoxic T lymphocyte generation. II. Differential effects of IL-6 on the helper cell-independent generation of CTL from CD8+ precursor subpopulations.
Bass HZ; Yamashita N; Clement LT
J Immunol; 1993 Sep; 151(6):2895-903. PubMed ID: 8376760
[TBL] [Abstract][Full Text] [Related]
8. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
[TBL] [Abstract][Full Text] [Related]
9. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic Effects of IL-33 on CD4
Alvarez F; Fritz JH; Piccirillo CA
Front Immunol; 2019; 10():522. PubMed ID: 30949175
[TBL] [Abstract][Full Text] [Related]
11. Memory CD8
Baumann C; Fröhlich A; Brunner TM; Holecska V; Pinschewer DD; Löhning M
Front Immunol; 2019; 10():1833. PubMed ID: 31447845
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.
Anichini A; Scarito A; Molla A; Parmiani G; Mortarini R
J Immunol; 2003 Aug; 171(4):2134-41. PubMed ID: 12902520
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells.
Smyth MJ; Ortaldo JR; Shinkai Y; Yagita H; Nakata M; Okumura K; Young HA
J Exp Med; 1990 Apr; 171(4):1269-81. PubMed ID: 1691263
[TBL] [Abstract][Full Text] [Related]
14. IL-33 in T Cell Differentiation, Function, and Immune Homeostasis.
Peine M; Marek RM; Löhning M
Trends Immunol; 2016 May; 37(5):321-333. PubMed ID: 27055914
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes.
Inge TH; McCoy KM; Susskind BM; Barrett SK; Zhao G; Bear HD
J Immunol; 1992 Jun; 148(12):3847-56. PubMed ID: 1602133
[TBL] [Abstract][Full Text] [Related]
16. Ly49D engagement on T lymphocytes induces TCR-independent activation and CD8 effector functions that control tumor growth.
Merck E; Voyle RB; MacDonald HR
J Immunol; 2009 Jan; 182(1):183-92. PubMed ID: 19109149
[TBL] [Abstract][Full Text] [Related]
17. Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling.
Grange M; Verdeil G; Arnoux F; Griffon A; Spicuglia S; Maurizio J; Buferne M; Schmitt-Verhulst AM; Auphan-Anezin N
J Immunol; 2013 Oct; 191(7):3712-24. PubMed ID: 24006458
[TBL] [Abstract][Full Text] [Related]
18. Acute activation of CD8+ T lymphocytes in interleukin-2-treated HIV-infected patients. ANRS-048 IL-2 Study Group. Agence Nationale de Recherches sur le SIDA.
Zou W; Foussat A; Capitant C; Durand-Gasselin I; Bouchet L; Galanaud P; Levy Y; Emilie D
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):31-8. PubMed ID: 10534144
[TBL] [Abstract][Full Text] [Related]
19. IL-27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells.
Schneider R; Yaneva T; Beauseigle D; El-Khoury L; Arbour N
Eur J Immunol; 2011 Jan; 41(1):47-59. PubMed ID: 21182076
[TBL] [Abstract][Full Text] [Related]
20. LD1: a CD4-CD8- TCR alpha beta/CD3+ peripheral T cell line with helper function for B lymphocytes.
Pelkonen J; Palacios R
Int Immunol; 1990; 2(6):555-62. PubMed ID: 2150761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
